Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB1 | P08183 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.30 |
| ▸ | SELE | P16581 | 1/20 | 0.30 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15468476 | 0.72 | ICAM1 (0.30) | ICAM1SELE | |
| SCHEMBL1057083 | 0.72 | — | — | |
| SCHEMBL88301 | 0.70 | — | — | |
| SCHEMBL16803983 | 0.70 | ABCB1 (0.31) | ABCB1 | |
| SCHEMBL2212070 | 0.70 | — | — | |
| SCHEMBL1375865 | 0.69 | MAPT (0.35) | KMT2A | |
| SCHEMBL13270524 | 0.69 | MAPT (0.35) | KMT2A | |
| SCHEMBL2212653 | 0.67 | — | — | |
| SCHEMBL7751523 | 0.67 | — | — | |
| SCHEMBL10035662 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230150946-A1 | HETEROCYCLE CONTAINING STAT INHIBITORS AND COMPOSITIONS | OXFORD FINANCE LLC | 2023-05-18 | — | — | US | disclosed |
| US-20170204087-A1 | 2-OXINDOLE COMPOUNDS | CHEMOCENTRYX, INC. | 2017-07-20 | — | — | US | disclosed |
| US-8138231-B2 | Polymer having oxycarbon group, and use thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-03-20 | — | — | US | disclosed |
| US-20110224398-A1 | POLYMER HAVING OXOCARBON GROUP, AND USE THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-09-15 | — | — | US | disclosed |
| US-7981567-B2 | Polymer having oxocarbon group, and use thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-07-19 | — | — | US | disclosed |
| US-7842692-B2 | Azaindole derivative having PGD2 receptor antagonistic activity | SHIONOGI & CO., LTD. (JP) | 2010-11-30 | — | — | US | disclosed |
| US-20090197881-A1 | Azaindole Derivative Having PGD2 Receptor Antagonistic Activity | SHIONOGI & CO., LTD. (JP) | 2009-08-06 | — | — | US | disclosed |
| US-20090110994-A1 | POLYMER HAVING OXOCARBON GROUP, AND USE THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-04-30 | — | — | US | disclosed |
| US-20090110995-A1 | POLYMER HAVING OXYCARBON GROUP, AND USE THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-04-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230150946-A1 | HETEROCYCLE CONTAINING STAT INHIBITORS AND COMPOSITIONS | STAT5A, STAT5B, STAT3 | ABCB1 3786/4885KMT2A 2076/4885ICAM1 4851/4885 |
| US-20090197881-A1 | Azaindole Derivative Having PGD2 Receptor Antagonistic Activity | PTGDR, HRH2, PTGDR2 | ABCB1 1503/4885KMT2A 2290/4885ICAM1 2985/4885 |
| US-20170204087-A1 | 2-OXINDOLE COMPOUNDS | CCR9, CCR1, CCRL2 | ABCB1 1095/4885KMT2A 3106/4885ICAM1 2674/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.